Posts in tag
Amgen
Guardant Health and Amgen to Develop CDx Test for AMG 510 in KRAS G12C+ NSCLC
To support the commercialization of the blood-based companion diagnostic (CDx) test Guardant360 CDx for AMG 510, Guardant Health, Inc, will collaborate with Amgen, developer of AMG 510, and pursue an FDA Pre-Market Approval as a CDx for AMG 510 in patients with metastatic non–small cell lung cancer (NSCLC) with a KRAS G12C mutation, according to a press …
Celgene sells psoriasis pill to Amgen for $13.4b, on way to Bristol merger
Amgen said Monday that it will buy the psoriasis pill Otezla from Celgene (CELGZ), which is selling the medicine to remove an antitrust obstacle from its planned merger with Bristol-Myers Squibb. The purchase price for Otezla is $13.4 billion — higher than many analysts expected. Bristol-Celgene investors will surely be pleased about fetching such a …